BIG payment for young people with HIV
Official title: BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV
Run by University of Chicago · NCT07502365 · Data updated 2026-11-12
This study tests whether giving a basic income to young adults living with HIV helps them stay in care and achieve viral suppression better than usual care alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 304 (estimated) |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | July 29, 2026 |
| Main results expected | July 2030 |
| Study ends | July 2030 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT07502365 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-35 living with HIV, with recent gaps in care or unsuppressed viral load, who have financial distress and income at or below 250% of the federal poverty level, and who are English-speaking.
✕Probably not a fit
Participants without a financial need or those who do not experience barriers to care may see little or no additional benefit from the basic income intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial will compare Basic Income Guarantee plus standard HIV care versus standard care alone in adults aged 18-35 with HIV who have experienced financial hardship. Participants will be randomly assigned to one of the two groups and followed for 36 months, with up to 9 surveys and access to electronic medical record data for 54 months in total. The primary aim is to see if BIG improves engagement in care and viral suppression compared with treatment as usual. Eligibility includes living with HIV for at least two years, recent care gaps or unsuppressed viral load, income under 250% of the federal poverty level, and financial distress. The lead site is the University of Chicago, with NIMH collaboration, enrolling 304 participants recruited through community networks and HIV care providers.
Why it matters
Potential benefit: If successful, participants may experience improved engagement in care and better viral suppression, potentially reducing health risks and improving quality of life.
How similar studies have gone: Prior work suggests financial supports can influence health behaviors, but this exact Basic Income Guarantee approach for HIV care engagement is relatively novel and its effectiveness is being tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Living with HIV for 24 months or longer; * Ages 18-35; * English-speaking; * One or both of the following: 1. Experienced a gap in HIV provider care of 6 or greater months during the prior 12-month period; 2. Had an unsuppressed viral load at any point within the prior 12-month period (unsuppressed meaning a viral load of 200 copies/mL or higher); * Household income at or below 250% of the Federal Poverty Level; and * Experiencing financial distress, as based on a financial well-being score of 1-4 (high financial distress). Exclusion Criteria: * Unwilling/unable to provide informed consent * Unable to confirm HIV status * Unable to conduct the study in English
Where it's running
-
University of Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Jade Pagkas-Bather — University of Chicago
- Study coordinator: Jordan Victorian
- Email: jordan.victorian@bsd.uchicago.edu
- Phone: 773-702-5915
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
-
Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV
This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.